Mar 03

WS helps Genentech with FDA approval of new drug

Posted in: Uncategorized

WASHINGTON, DC: Weber Shandwick aided Genentech on communications work leading to approval from the Food and Drug Administration (FDA) of Avastin, a drug used in treating metastatic breast cancer, sources told PRWeek.

Related posts:

  1. Asia and Australia slam Premier League’s expansion plans LONDON - Australia and Asia's football associations have rejected the...
  2. Moving People charities search for ad agency LONDON - Moving People, a consortium of mental health charities,...
  3. Modular Furniture – Pantonova Chrome Sectional Couch (GALLERY) (TrendHunter.com) When furniture becomes art, it also becomes timeless....
  4. McD’s Teaches Kids How to Trash Talk Yes I'm up way later than I should be...
Tags:
No Responses to “WS helps Genentech with FDA approval of new drug”

Post a Comment